Email Updates

Search form

You are here

OB-002H

Status
Planned
Phase
I
Objective

This is a safety and acceptability study of the OB-002H gel which is a topical formulation of OB-002 (5P12-RANTES), a novel chemokine analogue that binds to the CCR5 receptors in order to prevent HIV infection. 

Prevention Option(s)
Microbicides
Enrollment
30
Population
MSM
Women
Sites

Site(s)-Poland

Poland